290,00EGP

-4,00EGP

-1,36%

13:29:23

EGX

Memphis Pharmaceutical & Chemical Industries für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 908938 / ISIN: EGS38351C010

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Memphis Pharmaceutical & Chemical Industries Times and Sales (EGX)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Memphis Pharmaceutical & Chemical Industries

Weitere Meldungen

14:00		The High-Stakes Battle for Invisible Real Estate in Space
13:30		Chevron Just Crushed Earnings. Here's What It Means for the Dividend.
13:15		Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That
13:00		The equal-weighted S&P 500 just smoked the Nasdaq-100 in July — outperforming amid the violent chip-stock unwind
13:00		heise-Angebot: Raus aus dem Chat: So entwickeln Sie wiederverwendbare Prompts für KI-Workflows
13:00		1 Incredible Stock-Split Stock to Buy With $200 Right Now
12:51		Zu viele Fake News: Google stoppt KI-Bilder-Funktion in Google Earth
12:47		Iran warns neighbors against being US 'defensive shield'
12:45		Greg Abel's Berkshire Hathaway May Have Repurchased Up to $11 Billion of Its Own Stock in Q2, a Bullish Signal for Shareholders
12:36		A Sizable "Trump Bump" for Social Security's 2027 COLA May Put America's Leading Retirement Program in Dire Straits
12:17		$10,000 Invested in Rocket Lab 3 Years Ago Is Worth This Much Today, Even After a 61% Drawdown.
12:15		Here's Why I Keep Buying This 10%-Yielding Dividend Stock
12:06		Prediction: Rocket Lab Will Turn Profitable and Free-Cash-Flow-Positive in 2027 -- Thanks to Iridium
12:05		Peter Lynch Had a Keen Eye for Spotting Ten-Bagger Stocks. Here's Why On Holding Checks Every Box.
12:02		The Impact Trump's Tariffs Are Having on Your 401(k)
11:53		Coinbase Reports Record Share of Global Crypto Trading Volume, But Its Price Still Drops. What Does That Mean For COIN Investors?
11:30		Here's How Much of the Schwab U.S. Dividend Equity ETF You'd Need to Cover Your Grocery Bill Every Month
11:25		Nvidia Isn't the Most Valuable Company in the World Anymore. Is More Bad News Coming?
11:15		Warren Buffett Has Endorsed Passive Investing for Decades. Here's the Exact Investment He Recommends Most People Buy.
11:12		Texas Instruments Stock Is Down 16% From Its 52-Week High. Is It a Buy?
11:08		Coca-Cola: The Surprising Reason Investors Should Choose Its Stock Over PepsiCo's
11:02		The Fight Over the World’s Oldest Bank
11:01		Is A.I. ‘Scheming’ Against Us?
11:00		‘We didn’t feel safe’: Booking.com users face battle to get money back
11:00		Leaving Property to Your Heirs Can Lead to Headache, not Robust Wealth
11:00		Carmakers Go Back to the ’80s With Turbo Engines
10:48		Claiming Social Security at 62 Might Pay You Less Per Month and in Your Lifetime. Here's Why You May Want to Do It Anyway.
10:48		Prediction: The Stock Market Will Hit Big Trouble in August. Here's How Much the S&P 500 Will Drop if History Repeats.
10:44		Prediction: SpaceX Stock Is About to Sink Even More After Plunging Over 40%
10:26		Palantir CEO Alex Karp Says Anthropic's Dario Amodei Isn't the 'Caricature' Most Americans Think— but Still Calls AI Rivals 'Wildly Unlikable'
10:11		Prediction: Bloom Energy Doubles Its Revenue Again by 2029. Here's the Math.
10:00		Is TerraPower the Next Oklo? Inside Bill Gates' Nuclear Bet.
09:30		Kevin Warsh Did Not Impress the Bond Market -- 30-Year Yields Are Up to 5.2%. Here's What This Might Mean for Investors in These 2 ETFs.
09:12		Scott Bessent's Notepad Was Accidentally Photographed At Camp David— and It Shows a Plan to Buy Up To $10 Billion in Japanese Yen
09:11		Netflix Is 43% Below Its 52-Week High at 20 Times Forward Earnings. Where Will the Stock Be in 3 Years?
09:10		Trump Says the Market Is Going to "Go Through the Roof." His Iran Escalation and New Tariffs Suggest Otherwise.
09:05		Scott Strazik's GE Vernova Has a $176 Billion Backlog. So Why Did Wall Street Sell the Stock?
08:55		Amazon vs. Microsoft vs. Alphabet: Which Is the Best Cloud Stock to Buy Now?
08:43		Germany news: Pride marches planned after Berlin attack
08:35		Adam Schiff Accuses Trump of Being 'Laser Focused' on Enriching His Family Through $8.9 Billion in Mineral Deals— Says He's 'Pressing for Answers' With Elizabeth Warren
08:20		Trump Says US Hasn't Approved Ukraine's Patriot Missile Production Request Despite Zelenskyy Promise: 'They Can Someday Turn on You'
08:13		George Santos Bet Against His Own State of the Union Attendance on Kalshi— Now He's Paying $35,000 to Settle CFTC Charges
08:05		Starbucks vs. Chipotle: Both Restaurants Are Seeing Turnarounds, but Which Stock Is the Better Buy Today?
07:30		Here's What Billionaire Bill Ackman Would Buy if He Were Just Getting Started With $1,000
07:28		Anthony Scaramucci Says His 'Fully Flammable' $90 Polyester Suit Almost Sank His Goldman Sachs Career Before It Started: 'I Thought I Looked Fantastic...'
07:15		Tesla's $99-a-Month FSD Plan Is on Pace to Generate $1.8 Billion a Year. Is This New Profit Lever a Signal to Buy the Elon Musk-Led Stock?
06:38		If You'd Invested $10,000 in Microsoft the Day Satya Nadella Became CEO, Here's What You'd Have Now.
06:29		Rivian's E-Bike Spinoff Finally Starts Shipping — Months After Angry Customers Began Canceling Orders: Report
06:15		NIO Inc. Provides July 2026 Delivery Update
06:14		OpenAI Investigates More Autonomous AI Agent Breakouts After Hugging Face Hacking Incident Draws Global Attention: Report

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: El-Nile Rowad Tourism Bank of Alexandria Egyptians Housing Development & Reconstruction US Bancorp Deposit Shs Repr 1-25th Non-Cum Perp

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	01.08.2026 14:16
Kaufwert:	EUR
	Hinzufügen Speichern

Memphis Pharmaceutical & Chemical Industries Aktie

WKN: 908938 / ISIN: EGS38351C010

Memphis Pharmaceutical & Chemical Industries Times and Sales (EGX)

Times and Sales

Analysen zu Memphis Pharmaceutical & Chemical Industries

Weitere Meldungen